Anxiety · Child & Teen Mental Health · PMHNP-BC Verified

Anxiety in Children: Signs, Causes & When to Seek Help

Written by Vaishali Desai, PMHNP-BC

Anxiety is the most common mental health condition in children. The CDC estimates that 7.1% of children ages 3–17 in the United States have diagnosed anxiety — a figure that almost certainly underrepresents actual prevalence, since childhood anxiety is still widely missed, misattributed to personality, and undertreated.

What makes pediatric anxiety difficult to recognize is that children do not typically say “I feel anxious.” They say their stomach hurts. They refuse to go to school. They have meltdowns before birthday parties. They become clingy at drop-off in ways that seem like regression. They are described by teachers as “quiet” or by parents as “sensitive.” None of these are personality characteristics. They are symptoms.

Why Childhood Anxiety Looks Different From Adult Anxiety

Adults with anxiety typically recognize and can name the emotion. Children — particularly younger children — do not have the developmental or verbal capacity to identify and communicate internal emotional states with that specificity. The anxiety manifests through available channels:

  • Somatic complaints: Stomachaches, headaches, nausea, chest tightness before school, before social events, during transitions. These are real physical symptoms — the nervous system is producing them — but they consistently cluster around anxiety-provoking situations. When medical workup is negative and timing is predictable, anxiety is the diagnosis to pursue.
  • School refusal: The child who is consistently sick on Monday mornings, who has physical symptoms that resolve by noon once the school window has passed, or who escalates dramatically at drop-off is describing anxiety through behavior. School refusal is not defiance — it is avoidance, and avoidance is the cardinal behavioral feature of anxiety.
  • Clinginess: Excessive attachment to a caregiver past the developmentally expected separation anxiety window (normal at 8–14 months, typically resolving by age 3–4) signals pathological separation anxiety.
  • Nightmares and sleep disruption: Chronic nightmares, difficulty falling asleep (checking behaviors, needing a parent present), and night waking are common anxiety presentations in children.
  • Anger and irritability rather than worry: Older children and adolescents often present with anger and emotional dysregulation rather than verbalized worry. The anxiety is experienced as agitation, and it reads as behavior problems or mood problems rather than anxiety.

The Developmental Trajectory of Anxiety

Not all anxiety at every age is pathological — some anxiety is developmentally normative and resolves without intervention. The clinical challenge is distinguishing normative anxiety from a disorder requiring treatment.

  • Separation anxiety: Normal from approximately 8–14 months, typically resolves by age 3. When separation anxiety persists past 3 or causes significant functional impairment (school refusal, inability to attend sleepovers or activities), Separation Anxiety Disorder is the appropriate diagnosis.
  • Specific phobias: Fears of animals, the dark, loud noises, and similar stimuli are common and expected in preschool-age children. Most resolve with development. Phobias that persist past developmentally appropriate ages or produce significant avoidance and impairment warrant treatment.
  • Social anxiety: Peaks in early adolescence, consistent with the social cognition development happening in this period. Social anxiety is one of the most frequently missed diagnoses in adolescence — it often looks like “introversion” or “shyness” and carries a mean age of onset of 13 with a diagnostic delay averaging 15+ years.
  • GAD: Generalized anxiety disorder in children presents as excessive, hard-to-control worry across multiple domains — school performance, family safety, natural disasters, future events. Children with GAD are often described as “little adults” or “overthinkers” and the clinical picture is missed because they appear mature and responsible.

The Accommodation Trap: Why Helping Maintains the Anxiety

The most counterintuitive finding in pediatric anxiety research is that parental accommodation — the natural, loving response of helping a child avoid or escape anxiety-provoking situations — is one of the strongest predictors of anxiety maintenance.

Eli Lebowitz at the Yale Child Study Center developed the SPACE program (Supportive Parenting for Anxious Childhood Emotions) specifically to address this. SPACE is a parent-only intervention — no child sessions required — that teaches parents to systematically reduce accommodation while providing empathy and support. RCT data shows SPACE is as effective as CBT with the child directly, and more accessible for families whose children refuse treatment.

Accommodation includes: answering reassurance-seeking questions repeatedly, staying with the child during anxiety-provoking situations, modifying family routines to avoid triggers, allowing the child to avoid feared situations, and speaking for the child in social situations. Every accommodation signals to the brain that the feared thing was genuinely dangerous and required protection — and strengthens the anxiety circuit rather than weakening it.

Clinical Note: The accommodation trap is one of the most important concepts for parents of anxious children to understand — not to feel guilt about past accommodations, but to understand what treatment needs to do. Reducing accommodation is hard. It requires tolerating your child's distress in the short term to support recovery in the long term. No parent does this instinctively. It needs to be taught and supported.

School Refusal: The Pediatric Anxiety Emergency

School refusal is not simply a behavior problem or a parenting failure. It is one of the most impairing presentations of childhood anxiety — and one of the most time-sensitive to address, because avoidance compounds.

Each day a child successfully avoids school teaches the anxious brain that school is something to be avoided. The avoidance provides relief, which reinforces the avoidance. Each missed day also increases the social and academic anxiety of return — the longer the absence, the higher the perceived barrier to going back. Weeks become months. The academic and social consequences compound in ways that outlast the anxiety itself.

The clinical consensus is that school attendance must be prioritized early and rapidly in treatment. Return-to-school plans, graded exposure, and — when necessary — medication to reduce the physiological anxiety enough to make school attendance possible, are all part of the evidence-based approach. This is not a situation where watchful waiting is appropriate.

Selective Mutism: Anxiety, Not Behavior

Selective mutism — the consistent failure to speak in specific social situations (typically school) despite speaking normally at home — is an anxiety disorder, not a behavior or willfulness problem. Children with selective mutism typically do not choose to be silent. The anxiety response when expected to speak in certain contexts is so severe that speech is neurologically blocked.

Selective mutism is classified in DSM-5 under anxiety disorders. It is highly co-occurring with social anxiety disorder and responds to the same evidence-based treatments: graduated exposure, parent coaching, and SSRIs when indicated. Behavioral interventions that punish or shame the silence worsen it. Early identification and intervention (before school-based social dynamics solidify) produces the best outcomes.

ACEs, Early Adversity, and PANDAS/PANS

Adverse Childhood Experiences

Adverse childhood experiences (ACEs) — abuse, neglect, household dysfunction, parental mental illness, domestic violence, substance use — sensitize the HPA (hypothalamic-pituitary-adrenal) axis. Children raised in environments with chronic unpredictable stress develop a calibrated hypervigilance that serves a protective function in that environment. When the environment changes, the nervous system doesn't automatically recalibrate — the threat-response threshold stays low. This is not weakness; it is adaptive biology that has outlasted the context that shaped it. Understanding ACEs in a child's history changes the clinical picture and the treatment approach.

PANDAS/PANS: The Often-Missed Category

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal infections) and the broader PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) describe a distinct clinical presentation: abrupt, dramatic onset of OCD symptoms, anxiety, tics, or behavioral changes — often following a streptococcal or other infectious illness.

PANDAS/PANS is controversial in terms of prevalence and mechanism (autoimmune vs. neuroinflammatory), but the clinical presentation is distinct enough that it deserves consideration when anxiety or OCD symptoms in a child appear suddenly and dramatically following illness, particularly strep. Standard anxiety treatment protocols often do not fully address the autoimmune/infectious driver — workup and co-management with a pediatric specialist is appropriate when the presentation fits.

First-Line Treatment: CBT With Exposures and Parent Coaching

Cognitive-behavioral therapy (CBT) with exposure components is the gold-standard first-line treatment for childhood anxiety disorders. The evidence base is strong across all pediatric anxiety presentations — separation anxiety, social anxiety, GAD, specific phobias, and OCD.

Evidence-based programs include:

  • CAMS (Child/Adolescent Anxiety Multimodal Study protocol) — CBT with or without sertraline; RCT data shows 81% response rate for combination treatment
  • SPACE (Supportive Parenting for Anxious Childhood Emotions) — parent-focused intervention, as effective as child-focused CBT in RCTs, no child sessions required
  • Cool Kids, Coping Cat, and related manualized CBT programs

Parent involvement is essential regardless of which CBT approach is used. Parents who understand the accommodation trap, who can support graduated exposures at home, and who can tolerate their child's distress without rescuing are critical to treatment success. Family-based CBT consistently outperforms child-only treatment for pediatric anxiety.

Written by a PMHNP-BC

Anxiety 101: Understanding Your Anxiety & Building Your Toolkit

The neuroscience of anxiety, how to identify your pattern, what medication does and doesn't do, and how to build a practical toolkit for managing anxiety in daily life.

⚡ Instant download — available immediately after purchase

Medication for Pediatric Anxiety: What's Approved and What's Actually Used

Medication for childhood anxiety is more nuanced than most parents realize, because the FDA approval landscape doesn't reflect actual clinical practice.

FDA-approved for pediatric OCD:

  • Fluoxetine (Prozac) — approved for OCD, ages 7 and up
  • Fluvoxamine (Luvox) — approved for OCD, ages 8 and up
  • Sertraline (Zoloft) — approved for OCD, ages 6 and up
  • Clomipramine (Anafranil) — approved for OCD, ages 10 and up

Off-label but widely used for pediatric GAD and social anxiety: Fluoxetine and sertraline are the most commonly prescribed SSRIs for childhood anxiety disorders more broadly. The evidence base for their use in non-OCD pediatric anxiety is strong (CAMS trial data), even without FDA indication specifically for those diagnoses.

The Black Box Warning in Context

All SSRIs carry an FDA black box warning for increased risk of suicidal thinking in children, adolescents, and young adults (up to age 24). This warning is based on pooled clinical trial data showing a small but statistically significant increase in suicidal ideation (not completed suicide) in SSRI-treated youth compared to placebo.

The clinical context: the absolute risk increase in the pooled data was approximately 2% (4% SSRI vs. 2% placebo). No completed suicides occurred in these trials. Meanwhile, untreated depression and anxiety are themselves major risk factors for suicidal ideation. The black box warning is a risk to monitor for — particularly in the first 1–4 weeks — not a contraindication. Close follow-up after initiation (weekly contact in the first month) is standard of care.

Prescriber's Note: “When I prescribe an SSRI to a child or adolescent, I always walk the family through the black box warning explicitly — not to frighten them, but because a parent who reads it on the package insert without context is far more likely to stop the medication abruptly. I explain that we watch for it, that we check in frequently in the first month, and that the risk of not treating severe anxiety is real and measurable too. Informed families make better treatment decisions.” — Vaishali Desai, PMHNP-BC

When to Refer: Pediatric Psychiatrist vs. CBT Therapist

The referral decision depends on what the primary gap is:

  • CBT therapist first: For most children with anxiety in the mild-to-moderate range without significant medication need, a CBT therapist with pediatric anxiety experience is the right starting point. Look specifically for training in exposure-based CBT, not generic talk therapy.
  • Pediatric psychiatrist when: Medication is indicated but a pediatrician or primary care provider is uncomfortable prescribing; the presentation is complex (multiple diagnoses, atypical features, treatment non-response); there's a question about diagnosis that needs expert evaluation; or the presentation is severe (school refusal with significant academic impact, significant functional impairment, or suicidal ideation).
  • Both together: For moderate-to-severe anxiety, the combination of medication and CBT produces superior outcomes to either alone — the CAMS trial found 81% response to combination vs. 60% for either monotherapy.

How to Talk to Your Child About Therapy and Medication

The language matters and should be age-calibrated:

For younger children (5–8): “Your brain has a worry alarm that goes off a lot. It's trying to protect you, but sometimes it goes off too much, even when there's nothing actually dangerous. The person we're going to see is a worry coach — they help kids teach their brains when it's okay to turn the alarm down.”

For older children and teens (9–14): “Anxiety is when your nervous system goes into alert mode more than it needs to. Therapy for anxiety is like a training program — it teaches your brain that the things you're afraid of aren't as dangerous as it thinks. It uses exposures — gradually facing things you worry about so your brain can learn they're manageable.”

About medication (for teens): “The medication doesn't make you a different person and it's not going to make you not care about things. It turns down the volume on the anxiety enough so that the therapy work is actually possible. Think of it as making room for the skills to take hold. Most people don't stay on it forever.”

Vaishali Desai, PMHNP-BC is a Board-Certified Psychiatric Mental Health Nurse Practitioner with nearly 10 years of clinical experience in mental health. She is the founder of 360 Mental Healing LLC and 360 Mind Shop, created to give patients and families the clinical information they deserve in language they can actually use.

This article is for educational and informational purposes only. It does not constitute medical advice, a clinical assessment, or a provider-patient relationship. Always consult your licensed healthcare provider before starting, stopping, or changing any medication or treatment plan. If you are experiencing a psychiatric emergency, call or text 988 or go to your nearest emergency room.

Guides for Navigating Anxiety at Every Age

Two guides written by Vaishali Desai, PMHNP-BC — one covering anxiety neuroscience and toolkit-building, one focused on teen mental health and what adults and teens need to know together.

The content on this site is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Purchasing or reading these guides does not create a provider-patient relationship. Always consult a qualified healthcare provider before making any decisions about your mental health care or medications.